• Medical devices and tests have the potential to save resources and they need to be approved by the health plan • The US FDA defines a medical device as 1 :
o An instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including a component part or accessory which is: recognized in the official National Formulary, or the United States Pharmacopoeia, or any supplement to them, o Intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals, or o Intended to affect the structure or any function of the body of man or other animals, and which does not achieve its primary intended purposes through chemical action within or on the body of man or other animals and which is not dependent upon being metabolized for the achievement of any of its primary intended purposes • Some tests allow the clinical team to identify diseases, and others identify markers to increase the potential effectiveness of therapies 2 • A genetic test involves an analysis of human chromosomes, DNA, RNA, genes, and/or gene products (e.g., enzymes and other types of proteins), which is predominately used to detect mutations, genotypes, or phenotypes related to disease and health 4 • Healthcare providers in the US market currently have available 5 
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The TPG-National Payor Roundtable (TPG-NPRT) focuses on market access programs within the United States, is a subsidiary of The Pharmacy Group, and maintains a database of Chief Medical Officers and Chief Pharmacy Officers in the United States.
The JeSTARx Group provides evidence-based research and support to the healthcare Industry.
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